Moneycontrol PRO

business

Mkt size of latest generic drug is $300mn: Panacea Biotec

Rajesh Jain, joint managing director, Panacea Biotec expects the USFDA approval for the collaborated drug by next year to early-2016.

first published: Dec 19, 2014 03:00 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347